A review of in vivo and in vitro aspects of alcohol-induced dose dumping

Abstract

This review provides a comprehensive list of in vivo and in vitro studies that have investigated alcohol induced dose dumping (AIDD) in modified release dosage forms. Of the numerous classes of drugs commercially available as modified release products, opioids, centrally acting drugs, and drugs with a narrow therapeutic index present high risks from dose dumping, despite being formulated in a manner that releases drug in a tailored or delayed fashion. Awareness of AIDD has led to the withdrawal of a few marketed products by Regulatory Agencies, and black box warnings on others. Since then, significant effort has focused on proving the robustness of a formulation when co-ingested with alcohol. Patient risk is deemed to be low if the formulation and its performance is unimpaired by the presence of 0–40% alcohol under in vivo and in vitro conditions.

More

Download
A review of in vivo and in vitro aspects of alcohol-induced dose dumping
Susan D’SouzaEmail author, Stephen Mayock and Alger Salt
AAPS Open2017
DOI: 10.1186/s41120-017-0014-9
art%3A10.1186%2Fs41120-017-0014-9.pdf
Adobe Acrobat Document 1.6 MB